14 insiders reported 57 Form 4 transactions for Intellia Therapeutics, Inc. (NTLA) over the past 18 months (most recent 2026-07-06). Recent activity: Dulac Edward J III (EVP, Chief Financial Officer) Sell 4,677 shares, Dube Michael P (VP, Chief Accounting Officer) Sell 2,641 shares, Cohen Fred E (Director) Buy 9,200 shares, Verwiel Frank (Director) Buy 9,200 shares, Goff Brian (Director) Buy 9,200 shares. Source: SEC Form 4.
| Date | Insider | Title | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-07-06 | Dulac Edward J III | EVP, Chief Financial Officer | Sell | 4,677 | $84,186 |
| 2026-07-06 | Dube Michael P | VP, Chief Accounting Officer | Sell | 2,641 | $44,316 |
| 2026-06-10 | Cohen Fred E | Director | Buy | 9,200 | $0 |
| 2026-06-10 | Verwiel Frank | Director | Buy | 9,200 | $0 |
| 2026-06-10 | Goff Brian | Director | Buy | 9,200 | $0 |
| 2026-06-10 | CHASE WILLIAM J | Director | Buy | 9,200 | $0 |
| 2026-06-10 | GOODMAN JESSE | Director | Buy | 9,200 | $0 |
| 2026-06-10 | Keresty Georgia | Director | Buy | 9,200 | $0 |
| 2026-06-10 | Bhanji Muna | Director | Buy | 9,200 | $0 |
| 2026-03-03 | Clark Eliana | EVP, Chief Technical Officer | Buy | 7,353 | $0 |
| 2026-03-03 | LEONARD JOHN M | President and CEO | Buy | 156,400 | $0 |
| 2026-03-03 | Dulac Edward J III | EVP, Chief Financial Officer | Buy | 61,280 | $0 |
| 2026-03-03 | Dube Michael P | VP, Chief Accounting Officer | Buy | 17,250 | $0 |
| 2026-03-03 | Schultes Birgit C | EVP, Chief Scientific Officer | Buy | 39,200 | $0 |
| 2026-03-03 | Clark Eliana | EVP, Chief Technical Officer | Sell | 607 | $8,364 |
| 2026-03-03 | Lebwohl David | EVP, Chief Medical Officer | Buy | 9,943 | $0 |
| 2026-03-03 | BASTA JAMES | EVP, General Counsel | Buy | 46,080 | $0 |
| 2026-03-03 | BASTA JAMES | EVP, General Counsel | Sell | 1,211 | $16,688 |
| 2026-01-07 | LEONARD JOHN M | President and CEO | Sell | 34,146 | $314,485 |
| 2026-01-07 | BASTA JAMES | EVP, General Counsel | Sell | 10,397 | $95,756 |
| 2026-01-07 | Dulac Edward J III | EVP, Chief Financial Officer | Sell | 6,379 | $58,751 |
| 2026-01-07 | Dube Michael P | VP, Chief Accounting Officer | Sell | 2,989 | $27,529 |
| 2026-01-07 | Lebwohl David | EVP, Chief Medical Officer | Sell | 11,903 | $109,627 |
| 2026-01-07 | Schultes Birgit C | EVP, Chief Scientific Officer | Sell | 8,508 | $78,359 |
| 2026-01-07 | Clark Eliana | EVP, Chief Technical Officer | Sell | 9,515 | $87,633 |
Source: SEC Form 4 filings · as of 2026-07-06